Log In
Print this Print this

Lipanthyl, Lipidil, TriCor, fenofibrate

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
DescriptionLipid regulating agent
Molecular Target Peroxisome proliferation activated receptor (PPAR) alpha
Mechanism of ActionPeroxisome proliferation activated receptor (PPAR) alpha agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Cardiovascular (unspecified)
Indication DetailsPrevent cardiovascular disease (CVD); Prevent cardiovascular disease (CVD) in Type II diabetes patients; Prevent major cardiovascular events in patients with Type II diabetes
Regulatory Designation
Partner AbbVie Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today